Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2019/04/018854
CTRI/2019/04/018854
Not yet recruiting
Phase 4

Comparison of the efficacy of Methotrexate (Mtx) and Apremilast (Apr) in psoriasis

Yenepoya Medical College0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Yenepoya Medical College
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •All patients visiting the Dermatology OPD diagnosed to have Psoriasis who needs systemic therapy.
  • •Patients requiring and willing to undergo treatment with Methotrexate or Apremilast

Exclusion Criteria

  • •1\.Patients who have taken systemic therapy in past three months or topical treatment or phototherapy in past 2 weeks
  • •2\.Who are lesser than 18 years of age.
  • •3\.Pregnant or those having any serious illness contraindicating systemic therapy.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
Assessing the effectiveness of methotrexate and actinomycin D in the treatment of patients with C-section ectopic pregnancy
IRCT20151020024625N16Iran University of Medical Sciences32
Not yet recruiting
Phase 3
Assessing the effectiveness of Methotrexat versus Azathioprine on disease activity index in Lichen planopilaris patients
IRCT20191006045005N2Esfahan University of Medical Sciences32
Not yet recruiting
Phase 4
METHOTREXATE VERSUS APREMILAST IN THE TREATMENT OF PLAQUE PSORIASISHealth Condition 1: L400- Psoriasis vulgaris
CTRI/2023/03/051052Trish Larissa Miranda
Active, not recruiting
Not Applicable
A Clinical trial to compare the effect of methotrexate alone and the effect of giving methotrexate along with atorvastatin for the treatment of psoriasis vulgarisHealth Condition 1: L400- Psoriasis vulgaris
CTRI/2018/10/016101SRM MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE
Not yet recruiting
Not Applicable
To compare how much the blood inflammatory markers are reduced in psoriasis patients after giving Methotrexate treatment in one group and Methotrexate-Metformin combination treatment in the other group
CTRI/2023/10/059175Saveetha Medical College